Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Comparison between nitroglycerin dermal patch and nifedipine for treatment of preterm labor: a randomized clinical trial

Journal of Perinatology volume 34, pages 683–687 (2014)Cite this article

Subjects

Abstract

Objective:

Preterm labor and delivery are of the most important complications of pregnancy and have a major role in neonatal mortality and morbidity. Management of preterm labor and prevention from preterm delivery in order to lower these risks have always been under serious concern. The purpose of this study was to compare the effect of nifedipine and nitroglycerin (NG) dermal patch for taking control of preterm labor.

Study Design:

The study was performed as a randomized clinical trial on women who had been admitted in the hospital diagnosed with preterm labor. In one group, the NG dermal patch and in the other group, nifedipine was prescribed. Then the women of the two groups were followed up to delivery and were compared according to arrest of labor for 2 h, 48 h, 7 days, gestational age at the time of delivery and their adverse effects. The primary outcome was to postpone delivery for 48 h in order to have enough time for prescribing corticosteroids

Result:

The women of the two groups did not have any significant difference according to age, body mass index, primary Bishop Score, gestational age at the time of tocolytic therapy, history of abortion, vaginal or cesarean delivery and preterm labor. In more women in the NG group, delivery was postponed for 2 h (59 (98.3%) vs 48 (80%), P=0.001), for 48 h (52 women (86.7%) vs 41(68.3%), P=0.016) and also for 7 days (47 (78.3%) vs 37 (61.7%), P=0.046), than the women in the nifedipine group. Gestational age at the time of delivery was higher in the NG group (35.6±1.9 vs 34.3±2.05 weeks, P=0.155), however, it was not statistically significant. Apgar score of minute 5, (P=0.03) and neonatal weight (P=0.04), were more and cesarean deliveries, neonatal intensive care unit (NICU) admission and duration of NICU stay were less in the NG group. Adverse effects were similar, minimal and negligible in both groups.

Conclusion:

The NG patch is a more effective method for preterm labor control than nifedipine with regard to minimal side effects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

Article 16 February 2023

Evdokia Dimitriadis, Daniel L. Rolnik, … Ellen Menkhorst

References

  1. Cunninghan FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY . Williams Obstetrics 23rd edn MC Graw Hill Medical: New York, NY, USA, 804–831 2010.

    Google Scholar 

  2. Kam KY, Lament RF . Developments in the pharmaco therapeutic management of spontaneous preterm labor. Expert Opin Pharmacother 2008; 9 (7): 1153–1168.

    Article  CAS  Google Scholar 

  3. Kashanian M, Akbarian AR, Soltanzade M . Atosiban and nifedipine for the treatment of preterm labor. Int J Gynaecol Obstet 2005; 91 (1): 10–14.

    Article  CAS  Google Scholar 

  4. Leszczynska-Gorzelak B, Laskowska M, Marciniak B, Oleszczuk J . Nitric oxide for treatment of threatened preterm labor. Int J Gynaecol Obstet 2001; 73 (3): 201–206.

    Article  CAS  Google Scholar 

  5. Pullen KM, Riley ET, Waller SA, Taylor L, Caughey AB, Druzin ML et al. Randomized comparison of intravenous terbutalin VS nitroglycerin for acute intra partum fetal resuscitation. AM J Obstet Gynecol 2007; 197 4 (414): e1–e6.

    Google Scholar 

  6. Black RS, Lees C, Thompson C, Pickles A, Campbell S . Maternal and fetal cardio vascular effects of trans dermal glyceril trinitrate and intravenous ritodrine. Obstet Gynecol 1999; 94 (4): 572–576.

    CAS  PubMed  Google Scholar 

  7. Chawalisz K, Garfield RE . Role of nitric oxide in the uterus and cervix; implications for the management of labor. J Perinat Med 1998; 26 (6): 448–457.

    Article  Google Scholar 

  8. Smith GN, Walker MC, Ohlsson A, O’ Brien K, Windrim R . Canadian preterm labor nitroglycerin trial group Randomized double – blind placebo controlled trail of trans dermal nitroglycerin for preterm labor. Am J Obstet Gynecol 2007; 196 (1): 37e 1–38e.

    Article  Google Scholar 

  9. Rowlands S, Trudinger B, Visva-Lingam S . Treatment of preterm cervical dilatation with glyceryl trinitrate a nitric oxide donor. Aust N Z J Obstet Gynaecol 1996; 36 (4): 377–810.

    Article  CAS  Google Scholar 

  10. Amorim MM, Lippo LA, Costa AA, Coutinho IC, Souza AS . Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial. Rev Bras Ginecol Obstet 2009; 31 (11): 552–558.

    PubMed  Google Scholar 

  11. King JF, Flenady V, Papatsonis D, Dekker G, Carbo B . Calcium channel blockers for inhibiting preterm labor, a systematic review of the evidence and protocol for administration of nifedipine. Aust N Z J Obstet Gynecol 2003; 43 (3): 192–198.

    Article  Google Scholar 

  12. Lees CC, Lojacono A, Thompson C, Danti L, Black RS, Tanzi P et al. Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN, Preterm Labor Investigation Group. Obstet Gynecol 1999; 94 (3): 403–408.

    CAS  PubMed  Google Scholar 

  13. Duckitt K, Thomton S . Nitric oxide donors for the treatment of preterm labor. Cochrane Database Syst Rev 2002; (3): CD002860.

  14. Sheikh S, Sheikh AH, Akhter S, Isran B . Efficacy of trans dermal nitroglycerin in idiopathic preterm labor. J Pak Med Assoc 2012; 62 (1): 47–50.

    Google Scholar 

  15. Smith GN, GUO Y, Wen SW, Walker MC . Canadian Preterm Labor Nitroglycerin Trial Group Secondary analysis of the use of trans dermal nitroglycerin for preterm labor. Am J Obstet Gynecol 2010; 203 (6): 565.e1–565.e6.

    Article  CAS  Google Scholar 

  16. Morgan PJ, Kung R, Tarshis J . Nitroglycerin as a uterine relaxant: a systematic review. J Obstet Gynaecol Can 2002; 24 (5): 403–409.

    Article  Google Scholar 

  17. Guo Y, Longo CJ, Xie R, Wen SW, Walker MC, Smith GN . Cost - effectiveness of trans dermal nitroglycerin use for preterm labor. Value Health 2011; 14 (2): 240–246.

    Article  Google Scholar 

Download references

Acknowledgements

Trial registration number and registry website: IRCT201108262624N8.

Author information

Authors and Affiliations

  1. Department of Obstetrics & Gynecology, Iran University of Medical Sciences, Akbarabadi Teaching Hospital, Tehran, Iran

    M Kashanian & Z Zamen

  2. Middlesex University, Business School, London, UK

    N Sheikhansari

Authors
  1. M Kashanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Z Zamen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N Sheikhansari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M Kashanian.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kashanian, M., Zamen, Z. & Sheikhansari, N. Comparison between nitroglycerin dermal patch and nifedipine for treatment of preterm labor: a randomized clinical trial. J Perinatol 34, 683–687 (2014). https://doi.org/10.1038/jp.2014.77

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2014.77

Search

Advanced search

Quick links